Evaluating the Potential Pathology and Short-Term Outcomes of Cryptogenic Stroke Using the Etiological Classification System

Author:

Shimizu Takahiro1,Ueno Yuji2,Tateishi Yohei3,Doijiri Ryosuke4,Kuriki Ayako5,Kikuno Muneaki6,Takekawa Hidehiro7,Shimada Yoshiaki8,Kanemaru Kodai6,Kamiya Yuki5,Yamaguchi Eriko4,Koga Masatoshi9,Ihara Masafumi10,Tsujino Akira3,Hirata Koichi7,Hasegawa Yasuhiro1,Hattori Nobutaka2,Urabe Takao8

Affiliation:

1. Department of Neurology, St. Marianna University School of Medicine

2. Department of Neurology, Juntendo University Faculty of Medicine

3. Department of Neurology and Strokology, Nagasaki University Hospital

4. Department of Neurology, Iwate Prefectural Central Hospital

5. Department of Neurology, Showa University Koto Toyosu Hospital

6. Department of Neurology, Tokyo Medical University

7. Department of Neurology, Dokkyo Medical University

8. Department of Neurology, Juntendo University Urayasu Hospital

9. Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center

10. Department of Neurology, National Cerebral and Cardiovascular Center

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Reference37 articles.

1. 1) Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, Sacco RL, Connolly SJ and Cryptogenic Stroke EIWG: Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol, 2014; 13: 429-438

2. 2) Hart RG, Catanese L, Perera KS, Ntaios G and Connolly SJ: Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update. Stroke, 2017; 48: 867-872

3. 3) Sacco RL, Prabhakaran S, Thompson JL, Murphy A, Sciacca RR, Levin B, Mohr JP and Investigators W: Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis, 2006; 22: 4-12

4. 4) Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, Swaminathan B, Lavados P, Wang Y, Wang Y, Davalos A, Shamalov N, Mikulik R, Cunha L, Lindgren A, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi RJ, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni D, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, Endres M, Muir KW, Bornstein N, Ozturk S, O’Donnell MJ, De Vries Basson MM, Pare G, Pater C, Kirsch B, Sheridan P, Peters G, Weitz JI, Peacock WF, Shoamanesh A, Benavente OR, Joyner C, Themeles E, Connolly SJ and Investigators NE: Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med, 2018; 378: 2191-2201

5. 5) Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmunzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K, Committee R-SES and Investigators: Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. N Engl J Med, 2019; 380: 1906-1917

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3